Briefing

Featured article

Genmab acquires biotechnology company ProfoundBio in $1.8bn deal

Also in this section

News in Numbers

Latest News

Latest Deals

Project Updates

Trends & Insight

06/24/2024 12:32:21
  • Home | UK’s new Netflix-style funding model for antibiotics goes live
  • Editor's letter
  • Contents
  • Mimotopes Company Insight
  • Mimotopes
  • Nipro
  • Briefing
  • News in Numbers
  • Latest News
  • Latest Deals
  • Project Updates
  • Trends & Insight
  • Körber Company Insight
  • Körber
  • In Depth
  • UK’s new Netflix-style funding model for antibiotics goes live
  • Swiss biotech ecosystem recuperates from global financial instability
  • Can supermarket pharmacies plug urgent healthcare gaps?
  • Will WHO’s new guidance spur hepatitis B immunisation?
  • ASCO24: Moderna/MSD’s cancer vaccine may transform melanoma landscape
  • How patient advocacy can lead to more successful and meaningful clinical trials
  • Sponsored Supplements
  • Lactalis Ingredients
  • Avenga Company Insight
  • Listings
  • Events
  • Excellence Awards
  • Innovation Rankings
  • Buyer's Guides
  • Next issue
06/24/2024 00:00:00